Clinical Trial Update: LifeVest Safety and Efficacy in Real Life Settings in France

View source ↗

Summary

This clinical trial evaluated the LifeVest wearable defibrillator's safety and efficacy in real-life settings in France. Results were posted on 2024-12-09.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrhythmia
• Heart Failure
• Left Ventricular Systolic Dysfunction
• Sudden Cardiac Death

Drugs mentioned

• LifeVest

Snippet

Sponsor: Zoll Medical Corporation | Conditions: Sudden Cardiac Death, Left Ventricular Dysfunction | Status: COMPLETED | Results posted: 2024-12-09